Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Clinical trial NCT00735553 · TERMINATED
Trial details
- NCT number
- NCT00735553
- Sponsor
- Repros Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-08-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.